在 NKp46 过表达的转基因小鼠模型中增加 NK 细胞免疫。,Scientific Reports

当前位置： X-MOL 学术 › Sci. Rep. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

在 NKp46 过表达的转基因小鼠模型中增加 NK 细胞免疫。
Scientific Reports ( IF 3.8 ) Pub Date : 2017-Oct-12 , DOI: 10.1038/s41598-017-12998-w
Ariella Glasner ₁ , Batya Isaacson ₁ , Sergey Viukov ₂ , Tzahi Neuman ₃ , Nehemya Friedman _{4,

5} , Michal Mandelboim _{4,

5} , Veronika Sexl ₆ , Jacob H Hanna ₂ , Ofer Mandelboim ₁

Affiliation

自然杀伤 (NK) 细胞采用激活受体，如自然细胞毒性受体 (NCR：NKp30、NKp44 和 NKp46)，其中只有 NKp46 具有小鼠直系同源物 (Ncr1)，以消除异常细胞。NKp46/Ncr1 被认为是 NK 细胞的选择性标记，尽管它也存在于 ILC 的一个子集上，但它似乎没有功能。流感病毒血凝素 (HA) 是第一个为 Ncr1/NKp46 鉴定的配体，其次是其他病毒、细菌甚至真菌配体。NKp46/Ncr1 还识别未知的自身和肿瘤配体。在这里，我们描述了一种转基因小鼠的产生，其中 Ncr1 基因在 Rosa 基因座中表达，在与 Cre 转基因小鼠系杂交时允许 Ncr1/NKp46 在各种组织中表达的 floxed 终止序列之前。令人惊讶的是，虽然尝试了几次穿越，Ncr1 过表达仅在 cre 重组酶表达依赖于 Ncr1 启动子的情况下成功。NK 细胞中的 Ncr1 过表达增加了两种标志性 Ncr1 相关病理、流感病毒感染和 B16 黑色素瘤中的 NK 细胞免疫。这些数据表明，通过强制表达 NKp46/Ncr1 来增加 NK 细胞的细胞毒性可作为治疗各种病理和免疫治疗的潜在治疗机会。

"点击查看英文标题和摘要"

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.

Natural Killer (NK) cells employ activating receptors like the Natural Cytotoxicity Receptors (NCRs: NKp30, NKp44 and NKp46), of which only NKp46 has a mouse orthologue (Ncr1), to eliminate abnormal cells. NKp46/Ncr1 is considered a selective marker for NK cells, although it is also found on a subset of ILCs, where it appears to be without function. The influenza virus hemagglutinin (HA) was the first ligand identified for Ncr1/NKp46 followed by other viral, bacterial and even fungal ligands. NKp46/Ncr1 also recognizes unknown self and tumor ligands. Here we describe the generation of a transgenic mouse where the Ncr1 gene is expressed in the Rosa locus, preceded by a floxed stop sequence allowing Ncr1/NKp46 expression in various tissues upon crossing with Cre transgenic mouse lines. Surprisingly, while several crossings were attempted, Ncr1 overexpression was successful only where cre recombinase expression was dependent on the Ncr1 promoter. Ncr1 overexpression in NK cells increased NK cell immunity in two hallmark Ncr1 related pathologies, influenza virus infection and B16 melanoma. These data suggest that increasing NK cell cytotoxicity by enforced NKp46/Ncr1 expression serves as a potential therapeutic opportunity for the treatment of various pathologies, and in immunotherapy.

更新日期：2017-10-12

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南